Title: A Novel Way to Follow Triglyceride Metabolism using 13C MRS
1A Novel Way to Follow Triglyceride Metabolism
using 13C MRS
- D. K. Deelchand1, J. E. M. Snaar1, B. Ravikumar2,
- R. Taylor2 and P. G. Morris1
1Sir Peter Mansfield Magnetic Resonance Centre,
School of Physics and Astronomy, University of
Nottingham, Nottingham, U.K. 2Department of
Diabetes and Metabolism, University of
Newcastle-Upon-Tyne, Newcastle-Upon-Tyne, U.K.
2Introduction
- Triglycerides are the most common form of lipids
in the human body - They provide
- Insulation and protection for internal organs
- Important as energy sources
- Conventional methods to measure their
concentration - Morphometry
- Chemical analysis of tissue extracts
- Indirect calorimetry
3Introduction (2)
- Until recently in vivo magnetic resonance
spectroscopy (MRS) has been applied - To date, no technique to investigate postprandial
trafficking of dietary fatty acids in humans - Important in understanding e.g. type 2 diabetes
where recent evidence suggests that their high
lipid stores may contribute to insulin resistance - Mechanism poorly understood
4Aim
- To follow the metabolic turnover of lipid stores
in liver and calf muscle over a period of 24
hours following ingestion of a labelled lipid
using in vivo 13C NMR spectroscopy
5Methods
- 13C MRS measurements conducted on a 3T system
- Two homemade half-volume RF probes were used
(denoted as leg and liver coils) each consisted
of - a circular 13C surface coil (7 cm diameter) and
- quadrature proton coils (leg probe 12 cm
diameter and liver probe 13 cm diameter) - Formate used as concentration reference at centre
of 13C coil - Subject lay supine inside magnet for each
measurement - Vacuum pillows used to ensure accurate
positioning for subsequent measurements
6Parameters
- Simple 13C pulse acquire sequence with WALTZ-8
decoupling (766 Hz bandwidth) - CYCLOPS phase cycling
- TR 720 ms such that
- SAR for each coil was within required safety
limits and - allows enough time for the recovery of
longitudinal magnetisation due to T1 relaxation - Spectra collected in block of 500 scans with
spectral resolution of 6 minutes (1,500
acquisitions in total)
7Volunteers
Body mass index Waist-hip
ratio
8Labelled Lipid
- 98 U-13C algal lipid mixture consisting of
- Palmitic acid (45-55)
- Palmitoleic acid (10-15)
- Oleic acid (20-30)
- Linoleic acid (10-15)
- C C -
9Protocol
MR Spectroscopy
Calf Muscle
Liver
0 2 4 5
6 8 24
Time (hours)
Breakfast 3g Labelled Lipid
Meal
141.8g carbohydrate, 24.6g fat, 15.4g protein,
1232 kcal
101.5g carbohydrate, 21.1g fat, 30.5g protein,
733kcal
10Analysis
- Spectroscopic analysis with MRUI package in
MATLAB - AMARES algorithm used for peak fitting
- Prior knowledge (e.g. line-width, peak position
constraints) applied if/when needed - Estimate zero- and first- order phases for best
fit
11Quantification
- Two phantoms, similar in shape to liver and calf
muscle and containing 5.33 mmol/l of labelled
lipid solution (dissolved in deuterated
chloroform) - Incorporated labelled lipid concentration found
based on the increase in the ratio of the lipid
peak to the formate peak (??) from baseline - Where Rphantom is the ratio of the lipid to
formate peaks in the phantom
12Liver Spectra
- Unsaturated Carbons Saturated
Carbons
1313C Lipid Turnover in Liver
1413C Lipid Turnover in Muscle
15Lipoprotein Fractional Enrichment
From dietary fat
Synthesised by liver
16Exhaled Air 13CO2 Fractional Enrichment
17Summary
- Rapid incorporation of 13C enriched fatty acids
into liver (maximum at 6 hours plt0.01). Label
quickly displaced by subsequent unlabelled meals - Consistent with presence of high level of 13C
label in VLDL triglyceride at 8 hours - Substantial 13C level of VLDL throughout the 24
hours due to recycling of fatty acids - Modest uptake of labelled lipid in skeletal muscle
18Conclusion
- We have developed a novel 13C MRS protocol to
study the distribution and postprandial
metabolism of lipids in humans - Methodology will be applied to investigate the
possible role of lipids in mediating insulin
resistance in type 2 diabetes and non-alcoholic
steatohepatitis
19Acknowledgements
- Peter Morris
- Roy Taylor
- Angelien Snaar
- Balasubramanian Ravikumar
20Blood Glucose Insulin Levels